NEPH
Nephros Inc.
Latest price
As of Oct 30, 2026, 4:00 PM EDT · Market data by Massive
Market cap
$34.5M
Volume
12.4K
Previous close
$3.27
Day range
$3.17 – $3.50
Listed
Sep 21, 2004
Coverage
24 articles
Price performance
Recent trading
Newsroom
Latest NEPH coverage
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
[ad_1] Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ – (NewMediaWire) – March 07, 2024 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
[ad_1] SOUTH ORANGE, NJ – (NewMediaWire) – February 29, 2024 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will ho
Nephros Announces Results for Quarter Ended September 30, 2023
[ad_1] Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022;Net Loss from Continuing Operations Narrows 85% to $0.2 Million;$1.1 Million in Positive Year-to-Date Net Cash Flows from Operating Activities SOUTH ORANGE, NJ – (NewMediaWire) – November 08, 2023 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company pro
Nephros and Donastar Announce Strategic Partnership
[ad_1] Donastar Becomes Exclusive Master Distributor of Nephros Commercial Water Filtersfor Food & Beverage and Hospitality Markets SOUTH ORANGE, NJ – (NewMediaWire) – March 01, 2023 –Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced a new p
Nephros Announces Results for Quarter Ended September 30, 2022
[ad_1] Third-Quarter Net Revenue of $2.4 Million;Active Customer Sites Increase 18% YoY to a New Record Level SOUTH ORANGE, NJ – (NewMediaWire) – November 02, 2022 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the
Nephros Announces Results for Quarter Ended June 30, 2022
[ad_1] Second Quarter Net Revenue of $2.9 Million, a 27% Year-Over-Year Increase;Active Customer Sites Climb 21% to New Record SOUTH ORANGE, NJ – (NewMediaWire) – August 10, 2022 – Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, toda
Nephros Announces Results for Quarter Ended March 31, 2022
[ad_1] First Quarter Net Revenue of $2.2 Million;Active Customer Sites Climb 17% to New Record SOUTH ORANGE, NJ – (NewMediaWire) – May 04, 2022 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for
Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results
[ad_1] Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and Fourth Quarter Net Revenue of $2.8 Million, an 18% Year-Over-Year Increase;Reaffirms Fiscal Year 2022 Guidance of $13.0 Million to $13.5 Million in Annual Revenue SOUTH ORANGE, NJ – (NewMediaWire) – February 23, 2022 – Nephros, Inc.(Nasdaq: NEPH), a lea
Nephros Issues 2022 Shareholder Letter
[ad_1] SOUTH ORANGE, NJ – (NewMediaWire) – January 13, 2022 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today issued a 2022 letter to shareholders. Dear Shareholder, We are entering 2022 from our strongest position ever. 2021
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022
[ad_1] Anticipates Record Full-Year Net Revenue of $10.4 Million, a 21% Year-Over-Year Increase and Fourth Quarter Revenue of $2.8 Million, an 18% Year-Over-Year Increase;Provides 2022 Guidance of $13.0 Million to $13.5 Million in Annual Revenue SOUTH ORANGE, NJ – (NewMediaWire) – January 11, 2022 – Nephros, Inc. (Nasdaq: NEPH), a leading w
Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference
[ad_1] SOUTH ORANGE, NJ – (NewMediaWire) – November 23, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros will be attending the Benchm
Nephros Announces Results for Quarter Ended September 30, 2021
[ad_1] Third Quarter Net Revenue of $2.6 MillionUp 24% Year-Over-Year and 16% Quarter-over-Quarter SOUTH ORANGE, NJ – (NewMediaWire) – November 04, 2021 – Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced results for t
Nephros Announces Preliminary Results for Third Quarter of 2021
[ad_1] Anticipates Net Revenue of $2.6 Million, a 24% Year-Over-Year Increase SOUTH ORANGE, NJ – (NewMediaWire) – October 08, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the third q
Nephros Announces Results for Quarter Ended June 30, 2021
[ad_1] Second Quarter Net Revenue of $2.3 Million; 44% Year-Over-Year Increase; Strategic Acquisition of GenArraytion, Inc.; HDF Product Submitted to FDA for 510(k) Clearance SOUTH ORANGE, NJ – (NewMediaWire) – August 05, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading biotechnology company providing innovative filtration and pathogen detect
Nephros Announces Preliminary Results for Second Quarter of 2021
[ad_1] Anticipates Net Revenue of $2.2 Million, Greater Than 40% Year-Over-Year Increase; Submits HDF Product to FDA for 510(k) Clearance SOUTH ORANGE, NJ – (NewMediaWire) – July 08, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial m
Nephros CEO Presenting at Access to Giving Virtual Investor Conference
[ad_1] SOUTH ORANGE, NJ – (NewMediaWire) – July 9, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, has been invited to present at the Access to Giving Virtual Investor conference, which is being held July 13-15. Andy Astor, P
Nephros Announces Results for Quarter Ended March 31, 2021
[ad_1] Net Revenue of $2.7 Million; Highest First Quarter in Company History SOUTH ORANGE, NJ – (NewMediaWire) – May 06, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced results for the three months ended March
Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
[ad_1] SOUTH ORANGE, NJ – (NewMediaWire) – March 10, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Inaugural Emerging Growth Virtu
Nephros Reports 2020 Fourth Quarter and Full Year Financial Results
[ad_1] Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third QuarterFull Year Revenue $8.6 million, Down 17% Against Prior Year SOUTH ORANGE, NJ – (NewMediaWire) – March 01, 2021 – Nephros, Inc. (Nasdaq:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commer
Nephros Hires Wes Lobo as Chief Marketing Officer
[ad_1] SOUTH ORANGE, NJ – (NewMediaWire) – February 18, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced the appointment of Wes Lobo as Chief Marketing Officer, reporting directly to Nephros Chief Executive Off
Nephros Appoints Dan D'Agostino as CFO and Reports Third Quarter Financial Results
[ad_1] Finance Veteran Strengthens Management Team; Quarter-over-Quarter Net Revenue up 34%; Year-over-Year down 31% SOUTH ORANGE, NJ – (NewMediaWire) – November 5, 2020 – Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical
Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock
[ad_1] SOUTH ORANGE, NJ – (NewMediaWire) – October 16, 2020 – Nephros, Inc. (Nasdaq: NEPH)(“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced the pricing of a registered direc
Nephros Names Andy Astor President and Chief Executive Officer
[ad_1] Daron Evans to Remain Senior Science Advisor and CEO of Specialty Renal Products SOUTH ORANGE, NJ – (NewMediaWire) – August 14, 2020 – Nephros, Inc.(Nasdaq:NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced that
Nephros Reports Second Quarter Financial Results
[ad_1] Net Revenue down 32% due to COVID-19 Interruptions SOUTH ORANGE, NJ – (NewMediaWire) – August 05, 2020 – Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced financial results f